• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Kathy Oubre Explains How Biosimilar Savings Help Dispel Clinician Worries

Video

Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, explains how biosimilars are helping to rid clinicians of their worries about the affordability of biologic drugs.

Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, explains how biosimilars helping to rid worries about the affordability of biologic drugs helps clinicians.

Transcript:

How much of a relief to clinicians is it to have biosimilars for expensive reference products available?

Oubre: So, when talking about biosimilars within our organization, we often use the phrase "quality without compromise." And biosimilars have really helped kind of check that box because it allows us and our providers to provide the same high quality care to our patients, while decreasing some of that financial impact to them.

Related Videos
Lakesha Farmer, PharmD
GBW 2023 webinar
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
Michael Kleinrock
Michael Kleinrock
Ryan Haumschild, PharmD
Ryan Haumschild, PharmD, MS, MBA
Related Content
© 2024 MJH Life Sciences

All rights reserved.